| |
Cardiac
|
Skeletal Markers
| |
---|
Cell line
|
Conditions
|
GATA-4
|
Pax3
|
Gli2
|
Meox1
|
MRFs
|
Figure
|
---|
P19
|
-
|
-
|
-
|
-
|
-
|
-
|
Fig. 7 & Data not shown
|
P19
|
+DMSO
|
+
|
+
|
+
|
+
|
+
|
Figs. 1 & 4
|
P19
|
+DMSO&RA
|
-
|
+++
|
+
|
+++
|
+++
|
Figs. 1 & 4
|
P19 [β-cat/EnR]
|
+DMSO
|
N.D.
|
-
|
-
|
-
|
-
|
Figs. 3 & 4
|
P19 [β-cat/EnR]
|
+DMSO&RA
|
N.D.
|
+++
|
+++
|
-
|
-
|
Figs. 3 & 4
|
P19 [BMP]
|
-
|
-
|
-
|
-
|
-
|
-
|
Data not shown
|
P19 [BMP]
|
+DMSO
|
+
|
-
|
N.D.
|
-
|
-
|
Fig. 6, 7 & 8
|
P19 [BMP]
|
+DMSO&RA
|
+
|
+++
|
N.D.
|
N.D.
|
+++
|
Fig. 8
|
Mouse ES
|
-
|
+
|
-
|
N.D.
|
+/-
|
-
|
Fig. 2
|
Mouse ES
|
+RA
|
+/-
|
+++
|
N.D.
|
+++
|
+++
|
Fig. 2
|
- P19 cell lines indicated on the right were aggregated under the conditions described and the induction of muscle marker gene expression was monitored.
- (+++ = high expression; + = normal expression; +/- = partial expression, - = not expressed; N.D. = not determined)